Full Breakdown
Former USS Abraham Lincoln Sailors Plead Guilty to Fentanyl-Laced Pill Distribution
By Drooid · · How we work
Core Event: Guilty Pleas and Fatal Overdose
Two former U.S. Navy service members, Seaman Bailey A. Szramowski, 29, and Seaman Apprentice Johnnese H. Poomaihealani, 25, entered guilty pleas in federal court in San Diego for conspiracy to distribute controlled substances. They sold counterfeit oxycodone pills laced with fentanyl to active-duty sailors aboard the aircraft carrier USS Abraham Lincoln. One sailor, identified only by the initials A.N., purchased ten pills on December 30, 2022, and died of acute fentanyl intoxication on January 3, 2023, while on leave in San Leandro, California. Ten days later, another sailor, C.L., received three pills, overdosed, and was hospitalized after receiving naloxone. Szramowski faces a minimum of five years up to 40 years in prison and a $5 million fine; Poomaihealani faces up to 20 years and a $1 million fine. Sentencing is scheduled for later this year.
Background & Context
The USS Abraham Lincoln completed a nearly ten-month deployment that included more than 200 days in a combat zone supporting operations in Iran. During the deployment, concerns about sailor mental health and overall quality of life were publicly raised. The broader U.S. opioid crisis, driven largely by synthetic opioids such as fentanyl, has produced record overdose deaths, underscoring the lethal risk of counterfeit prescription pills circulating in military settings.
Data & Statistics
- Pills sold: 10 to A.N.; 3 to C.L.
- Fatalities: 1 death (A.N.).
- Hospitalizations: 1 overdose (C.L.) requiring naloxone.
- Sentencing ranges: Szramowski – 5 to 40 years, $5 million fine; Poomaihealani – up to 20 years, $1 million fine.
- Deployment dates: Szramowski aboard the Lincoln on June 6 2022; Poomaihealani on May 6 2022.
Official Statements & Responses
The U.S. Department of Justice, through the Southern District of California, confirmed the guilty pleas and detailed the charges. Prosecutors said the defendants knowingly sold fentanyl-containing pills and attempted to conceal their involvement by urging the victim’s relatives to delete text messages. Navy officials have not released a formal comment but have reiterated ongoing efforts to combat drug abuse within the fleet.
On-the-Ground Reports
Local investigators who responded to the A.N. overdose scene reported evidence of drug use at the residence and a toxicology report confirming fentanyl in the victim’s blood. The coroner’s autopsy listed acute fentanyl intoxication as the cause of death. In the C.L. incident, emergency responders administered naloxone, which reversed the opioid effects and saved the sailor’s life.
Conflicting Reports & Gaps
Sources differ on whether Szramowski was formally assigned to the USS Abraham Lincoln during the period of the drug sales. Some court documents state he “deployed on” the carrier, while other reports note uncertainty about his official assignment. No public information has been released regarding the extent of drug distribution beyond the two identified victims, leaving the full scope of the operation unclear.
Why It Matters
The case highlights vulnerabilities in drug control aboard naval vessels, especially during extended deployments where illicit substances can be obtained through mail-order channels and mobile payment apps. It also underscores the challenges the Navy faces in addressing substance abuse amid broader concerns about sailor welfare and mental health. The upcoming sentencing will set a precedent for how the military justice system penalizes illicit drug distribution that endangers service members.